ShanX Medtech, an Eindhoven-based MedTech company developing next-generation diagnostics for antimicrobial susceptibility testing, has secured €24 million in Seed financing to move its technology toward market launch.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?